It can stimulate the transcription of glucose transporter SLC2A3/GLUT3 through the HMGA1 binding site in the promoter, increase glucose uptake and ATP production, and protect tumour cells from metabolic stress. The gene discussed is HMGA1; the disease is neoplasm.